Celator Pharmaceuticals Stock Price, Forecast & Analysis (NASDAQ:CPXX) Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Celator Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume2.62 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Celator Pharmaceuticals, Inc is an oncology-focused biopharmaceutical company. The Company is engaged in developing products to improve patient outcomes in cancer. The Company's technology platform, CombiPlex, enables the design and evaluation of optimized combinations incorporating traditional chemotherapies, as well as molecularly targeted agents to deliver anti-cancer activity. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryN/A SectorN/A Current SymbolNASDAQ:CPXX Previous Symbol CUSIPN/A CIK1327467 WebN/A Phone+1-609-2430123Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Receive CPXX News and Ratings via Email Sign-up to receive the latest news and ratings for CPXX and its competitors with MarketBeat's FREE daily newsletter. Celator Pharmaceuticals (NASDAQ:CPXX) Frequently Asked Questions What is Celator Pharmaceuticals' stock symbol? Celator Pharmaceuticals trades on the NASDAQ under the ticker symbol "CPXX." How were Celator Pharmaceuticals' earnings last quarter? Celator Pharmaceuticals Inc (NASDAQ:CPXX) released its quarterly earnings data on Tuesday, May, 10th. The company reported ($0.16) EPS for the quarter, missing the consensus estimate of ($0.15) by $0.01. View Celator Pharmaceuticals' Earnings History. Has Celator Pharmaceuticals been receiving favorable news coverage? News articles about CPXX stock have been trending very negative this week, InfoTrie Sentiment reports. The research firm ranks the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Celator Pharmaceuticals earned a media sentiment score of -3.9 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Celator Pharmaceuticals. What other stocks do shareholders of Celator Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Celator Pharmaceuticals investors own include Sophiris Bio (SPHS), Consolidated Water (CWCO), Anavex Life Sciences (AVXL), Alder Biopharmaceuticals (ALDR), Sanchez Energy (SN), Fc Global Realty (FCRE), Chipotle Mexican Grill (CMG), Immunomedics (IMMU), Arena Pharmaceuticals (ARNA) and VASCO Data Security International (VDSI). How can I contact Celator Pharmaceuticals? Celator Pharmaceuticals' mailing address is 303b College Rd E, PRINCETON, NJ 08540-6608, United States. The company can be reached via phone at +1-609-2430123. MarketBeat Community Rating for Celator Pharmaceuticals (NASDAQ CPXX)Community Ranking: 3.0 out of 5 ( )Outperform Votes: 135 (Vote Outperform)Underperform Votes: 93 (Vote Underperform)Total Votes: 228MarketBeat's community ratings are surveys of what our community members think about Celator Pharmaceuticals and other stocks. Vote "Outperform" if you believe CPXX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CPXX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 11/20/2019 by MarketBeat.com StaffFeatured Article: What strategies should day traders use to execute a trade?